Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2012

View Archived Issues

New GlyT1 inhibitors patented

Nuvilex provides information on cell encapsulation technology

New nanovector platform allows noncovalent assembly of targeted therapeutics

Promedior closes financing round to advance pipeline

Dr. Falk Pharma obtains European rights to ulcerative colitis drug candidate

Dendritic cell-based vaccine is safe in patients with HIV

Novartis transfers marketing rights for ophthalmic solution

Taiho Pharmaceutical terminates licensing agreement for antipruritic agent

Aegerion Pharmaceuticals provides update on lomitapide NDA

Moberg Derma receives clearance for phase I Limtop trial

New phosphodiesterase 10A inhibitors reported by Evotec

Shionogi & Co. presents novel P2X3 and P2X2/3 receptor antagonists

Avedro submits NDA for corneal cross-linking system

S&T Global designs novel candidate antivirals

New PARP-1 inhibitors with anticancer potential developed in China

Roche divulges new seprase-specific antibodies

Research at Glycotope results in new potential cancer immunotherapies

Novel candidate schizophrenia therapeutics identified

Novel RIPK2 inhibitors reported by GlaxoSmithKline

Roche describes novel potential cancer therapeutics

Janssen unblinds phase III Zytiga study

Teva and OncoGenex amend custirsen advanced prostate cancer program

BioMarin completes enrollment in phase III BMN-110 trial

Transparency Life Sciences in-licenses ACE inhibitor

Novo Nordisk seeks Japanese approval for insulin degludec/insulin aspart coformulation

Peregrine reports topline clinical data on bavituximab

Inviragen reports topline results from HFMD vaccine study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...